Home › Funds › Rhenman & Partners Asset Management AB › VERA

Rhenman & Partners Asset Management AB position in VERA

VERA THERAPEUTICS INC · Health Care

Rhenman & Partners Asset Management AB reported holding 242,500 shares of VERA (VERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.8M, representing 0.87% of its reported portfolio and ranking #45 among its reported holdings. Rhenman & Partners Asset Management AB has disclosed VERA holdings in 3 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)242.50K sh
Reported value held$7.83M
Portfolio Weight0.87%
First reportedQ3 2025
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Rhenman & Partners Asset Management AB's VERA position evolved

Rhenman & Partners Asset Management AB first disclosed a stake in VERA in Q3 2025 at 130,000 shares (US$3.8M). The position peaked in Q4 2025 at 420,000 shares, worth US$21.3M. Across 3 filings, Rhenman & Partners Asset Management AB increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 242,500 shares valued at US$7.8M. Notable position changes include a 223% increase in Q4 2025 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 130.00K $3.78M New
Q4 2025 420.00K $21.27M Add
Q3 2026 242.50K $7.83M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VERA and 13F data

VERA (VERA THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in VERA — the largest reported positions include Avoro Capital Advisors LLC (US$245.6M), Deep Track Capital, LP (US$171.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$168.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VERA

All VERA fund holders →

FAQ

How long has Rhenman & Partners Asset Management AB held VERA?

Rhenman & Partners Asset Management AB has disclosed VERA holdings in 3 of the last 5 reported quarters, going back to Q3 2025.

What is Rhenman & Partners Asset Management AB's current position in VERA?

As of Q3 2026, Rhenman & Partners Asset Management AB holds 242.50K shares of VERA (VERA THERAPEUTICS INC), valued at $7.83M, representing 0.87% of its reported portfolio and ranking #45.

Has Rhenman & Partners Asset Management AB been buying or selling VERA?

In the latest 13F filing (Q3 2026), Rhenman & Partners Asset Management AB newly opened its position in VERA. The position peaked in Q4 2025 at 420.00K shares.

Which other funds hold VERA?

Other major institutional holders of VERA include Avoro Capital Advisors LLC, Deep Track Capital, LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.